| Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma A Navarro, T Diaz, A Martinez, A Gaya, A Pons, B Gel, C Codony, G Ferrer, ... Blood, The Journal of the American Society of Hematology 114 (14), 2945-2951, 2009 | 209 | 2009 |
| Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance C Moreno, K Hodgson, G Ferrer, M Elena, X Filella, A Pereira, T Baumann, ... Blood, The Journal of the American Society of Hematology 116 (23), 4771-4776, 2010 | 195 | 2010 |
| Chronic lymphocytic leukemia and autoimmunity: a systematic review K Hodgson, G Ferrer, E Montserrat, C Moreno Haematologica 96 (5), 752, 2011 | 174 | 2011 |
| Loss of PPARγ in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage … AJ Guri, R Hontecillas, G Ferrer, O Casagran, U Wankhade, AM Noble, ... The Journal of nutritional biochemistry 19 (4), 216-228, 2008 | 133 | 2008 |
| Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment K Hodgson, G Ferrer, A Pereira, C Moreno, E Montserrat British journal of haematology 154 (1), 14-22, 2011 | 111 | 2011 |
| Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis T Diaz, A Navarro, G Ferrer, B Gel, A Gaya, R Artells, B Bellosillo, ... PloS one 6 (4), e18856, 2011 | 91 | 2011 |
| Role of miR‐200 family members in survival of colorectal cancer patients treated with fluoropyrimidines T Diaz, R Tejero, I Moreno, G Ferrer, A Cordeiro, R Artells, A Navarro, ... Journal of surgical oncology 109 (7), 676-683, 2014 | 75 | 2014 |
| Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation CF de Larrea, A Navarro, R Tejero, N Tovar, T Díaz, MT Cibeira, L Rosinol, ... Clinical cancer research 18 (13), 3697-3704, 2012 | 71 | 2012 |
| Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene M Diaz-Beya, A Navarro, G Ferrer, T Diaz, B Gel, M Camos, M Pratcorona, ... Leukemia 27 (3), 595-603, 2013 | 66 | 2013 |
| Critical molecular pathways in CLL therapy G Ferrer, E Montserrat Molecular Medicine 24, 1-10, 2018 | 58 | 2018 |
| B cell activation through CD 40 and IL 4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL G Ferrer, R Bosch, K Hodgson, R Tejero, G Roue, D Colomer, ... British journal of haematology 164 (4), 570-578, 2014 | 50 | 2014 |
| Antidiabetic activity of extract and compounds from an endophytic fungus Nigrospora oryzae PF Uzor, PO Osadebe, NJ Nwodo Drug research 67 (05), 308-311, 2017 | 49 | 2017 |
| Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6–deficient process PEM Patten, G Ferrer, SS Chen, R Simone, S Marsilio, XJ Yan, Z Gitto, ... JCI insight 1 (4), 2016 | 38 | 2016 |
| Novel method for high-throughput full-length IGHV-DJ sequencing of the immune repertoire from bulk B-cells with single-cell resolution S Vergani, I Korsunsky, AN Mazzarello, G Ferrer, N Chiorazzi, D Bagnara Frontiers in Immunology 8, 1157, 2017 | 37 | 2017 |
| MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia G Ferrer, A Navarro, K Hodgson, M Aymerich, A Pereira, T Baumann, ... Leukemia & Lymphoma 54 (9), 2016-2022, 2013 | 37 | 2013 |
| Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies CA Garcia-Prieto, L Villanueva, A Bueno-Costa, V Davalos, ... JNCI: Journal of the National Cancer Institute 114 (3), 436-445, 2022 | 33 | 2022 |
| Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL G Ferrer, B Jung, PY Chiu, R Aslam, F Palacios, AN Mazzarello, ... Leukemia 35 (11), 3163-3175, 2021 | 28 | 2021 |
| miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia A Navarro, S Pairet, A Álvarez-Larrán, A Pons, G Ferrer, R Longarón, ... Blood Cancer Journal 6 (3), e406-e406, 2016 | 27 | 2016 |
| B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity G Ferrer, K Hodgson, E Montserrat, C Moreno Leukemia & lymphoma 50 (7), 1075-1082, 2009 | 25 | 2009 |
| Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target F Palacios, XJ Yan, G Ferrer, SS Chen, S Vergani, X Yang, J Gardner, ... Leukemia 35 (4), 1037-1052, 2021 | 24 | 2021 |
